Evidence map›Paper›PMID 22637743›Full record

ArticleCarcinogenesis2012

Genome-wide gene-environment interaction analysis for asbestos exposure in lung cancer susceptibility.

Sheng Wei, Li-E Wang, Michelle K McHugh, Younghun Han, Momiao Xiong, Christopher I Amos, Margaret R Spitz, Qingyi Wei Wei

Open access · bronzeAbstract read
In one paragraph

Article in Carcinogenesis, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. APE1 Asp148Glu polymorphism and lung cancer susceptibility.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Etiology of lung cancer: Evidence from epidemiologic studies.Journal of the National Cancer Center · 2022
    Review
  7. Article
  8. Article
  9. Asbestos, Smoking and Lung Cancer: An Update.International journal of environmental research and public health · 2019
    Review
  10. Review
  11. Article
  12. A Decade of GWAS Results in Lung Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2018
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2016
    Article
  18. Article
  19. In Search of 'Birth Month Genes': Using Existing Data Repositories to Locate Genes Underlying Birth Month-Disease Relationships.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2016
    Article
  20. Genome-wide Gene-Asbestos Exposure Interaction Association Study Identifies a Common Susceptibility Variant on 22q13.31 Associated with Lung Cancer Risk.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Sheng WeiDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA.
Li-E Wang
Michelle K McHugh
Younghun Han
Momiao Xiong
Christopher I Amos
Margaret R Spitz
Qingyi Wei Wei
The University of Texas MD Anderson Cancer Center · USUniversity of Houston · USHuazhong University of Science and Technology · CN

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Transdisciplinary Research in Cancer of the Lung (TRICL)U19CA148127 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I., LE MARCHAND, LOIC · 2010 to 2014
$10.9M
Molecular Epidemiology of Head and Neck CancerR01ES011740 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WEI, QINGYI · 2001 to 2012
$6.3M
ECOGENETIC STUDY OF LUNG CANCER IN MINORITIESR01CA055769 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SPITZ, MARGARET R · 1991 to 2008
$5.3M
Inflammation Genes and Lung Cancer RiskR01CA127219 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SPITZ, MARGARET R · 2008 to 2013
$3.1M
High Density Association Analysis of Lung CancerR01CA121197 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I. · 2007 to 2010
$3.0M
Genotypes and Phenotypes of Apoptosis and Risk of Head and Neck CancerR01CA131274 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WEI, QINGYI · 2009 to 2013
$3.0M
Statistical Methods for Finding Missing HeritabilityR01HL106034 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI XIONG, MOMIAO · 2011 to 2014
$1.5M
Unified Statistical Methods for Sequence-Based Association StudiesR01GM104411 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI XIONG, MOMIAO · 2013 to 2016
$1.3M
Network Approach to GWA Studies of Rheumatoid Arthritis (RA), Ankylosing SpondyliR01AR057120 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI XIONG, MOMIAO · 2009 to 2010
$554k
NCI NIH HHS CA121197NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA055769NCI NIH HHS R01CA055769NCI NIH HHS R01 CA121197NCI NIH HHS R01 CA127219NCI NIH HHS R01CA127219NCI NIH HHS R01 CA131274NCI NIH HHS R01CA131274NCI NIH HHS U19 CA148127NHLBI NIH HHS R01 HL106034NIAMS NIH HHS R01 AR057120NIEHS NIH HHS R01 ES011740NIEHS NIH HHS R01ES011740NIGMS NIH HHS R01 GM104411
6 · The paper itself

Abstract

Asbestos exposure is a known risk factor for lung cancer. Although recent genome-wide association studies (GWASs) have identified some novel loci for lung cancer risk, few addressed genome-wide gene-environment interactions. To determine gene-asbestos interactions in lung cancer risk, we conducted genome-wide gene-environment interaction analyses at levels of single nucleotide polymorphisms (SNPs), genes and pathways, using our published Texas lung cancer GWAS dataset. This dataset included 317 498 SNPs from 1154 lung cancer cases and 1137 cancer-free controls. The initial SNP-level P-values for interactions between genetic variants and self-reported asbestos exposure were estimated by unconditional logistic regression models with adjustment for age, sex, smoking status and pack-years. The P-value for the most significant SNP rs13383928 was 2.17×10(-6), which did not reach the genome-wide statistical significance. Using a versatile gene-based test approach, we found that the top significant gene was C7orf54, located on 7q32.1 (P = 8.90×10(-5)). Interestingly, most of the other significant genes were located on 11q13. When we used an improved gene-set-enrichment analysis approach, we found that the Fas signaling pathway and the antigen processing and presentation pathway were most significant (nominal P < 0.001; false discovery rate < 0.05) among 250 pathways containing 17 572 genes. We believe that our analysis is a pilot study that first describes the gene-asbestos interaction in lung cancer risk at levels of SNPs, genes and pathways. Our findings suggest that immune function regulation-related pathways may be mechanistically involved in asbestos-associated lung cancer risk.

Indexed as

Genetic Predisposition to DiseaseGenome, HumanAgedAsbestosFemaleHumansLung NeoplasmsMaleMiddle AgedPolymorphism, Single NucleotideAsbestos

Identifiers

PMID22637743
PMCPMC3499061
OpenAlexW2122782114

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.